RxDoctor Payments Data

Drew Brady, MD

Orthopaedic Surgery · Newark, DENPI 1477666790

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (37.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medacta USA, Inc. at 47.4% of the total. Reporting peaked in 2019 at $17,538 and has fallen 59.2% since, to $7,156 in 2025. Among orthopaedic surgery clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,292in general payments, 2019–2025

Across 193 payments — averaging $333.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$30K
  • Synthes GmbH$21K
  • Synthes USA Products LLC$6K
  • Stryker$4K
  • KCI USA, Inc.$1K
  • Johnson & Johnson$402
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$24,10037%
  • Speaking & faculty fees$15,00023%
  • Travel & lodging$19,00030%
  • Food & beverage$6,19210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,292 in reported general payments places this provider in the 90th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$441,720
Medicare patients
805
Services billed
6,017

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin78$280
Methylprednisolone35$248
Celecoxib11$222
Gabapentin23$110
Ibuprofen11$81
Oxycodone Hcl11$40

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →